Inorganic Chemistry
Article
(2) Meanwell, N. A. Synopsis of Some Recent Tactical Application
of Bioisosteres in Drug Design. J. Med. Chem. 2011, 54, 2529−2591.
(3) Kalgutkar, A. S.; Scott Daniels, J. S. Carboxylic Acids and their
Bioisosteres. In Metabolism, Pharmacokinetics and Toxicity of Func-
tional Groups: Impact of Chemical Building Blocks on ADMET; RSC
Drug Discovery series; Smith, D. A., Ed.; Royal Society of Chemistry:
Cambridge, 2010; pp 99−167.
(4) Lassila, T.; Hokkanen, J.; Aatsinki, S. M.; Mattila, S.; Turpeinen,
M.; Tolonen, A. Toxicity of Carboxylic Acid-Containing Drugs: The
Role of Acyl Migration and CoA Conjugation Investigated. Chem. Res.
Toxicol. 2015, 28, 2292−2303.
(5) Pajouhesh, H.; Lenz, G. R. Medicinal Chemical Properties of
Successful Central Nervous System Drugs. NeuroRx 2005, 2, 541−
553.
(21) Pichota, A.; Duraiswamy, J.; Yin, Z.; Keller, T. H.; Alam, J.;
Liung, S.; Lee, G.; Ding, M.; Wang, G.; Chan, W. L.; Schreiber, M.;
Ma, I.; Beer, D.; Ngew, X.; Mukherjee, K.; Nanjundappa, M.; Teo, J.
W.; Thayalan, P.; Yap, A.; Dick, T.; Meng, W.; Xu, M.; Koehn, J.; Pan,
S. H.; Clark, K.; Xie, X.; Shoen, C.; Cynamon, M. Peptide
Deformylase Inhibitors of Mycobacterium Tuberculosis: Synthesis,
Structural Investigations, and Biological Results. Bioorg. Med. Chem.
Lett. 2008, 18, 6568−6572.
(22) Puerta, D. T.; Cohen, S. M. Examination of Novel Zinc-Binding
Groups for Use in Matrix Metalloproteinase Inhibitors. Inorg. Chem.
2003, 42, 3423−3430.
(23) Jacobsen, F. E.; Lewis, J. A.; Cohen, S. M. A New Role for Old
Ligands: Discerning Chelators for Zinc Metalloproteinases. J. Am.
Chem. Soc. 2006, 128, 3156−3157.
(24) Sun Cao, P.; Sommer, R. D.; Grice, K. A. Structural
Comparison of Suberanilohydroxamic acid (SAHA) and Other
Zinc-Enzyme Inhibitors Bound to a Monomeric Zinc Species.
Polyhedron 2016, 114, 344−350.
(6) Rautio, J.; Kumpulainen, H.; Heimbach, T.; Oliyai, R.; Oh, D.;
Jarvinen, T.; Savolainen, J. Prodrugs: Design and Clinical
Applications. Nat. Rev. Drug Discovery 2008, 7, 255−270.
(7) Ballatore, C.; Huryn, D. M.; Smith, A. B. Carboxylic Acid
(Bio)Isosteres in Drug Design. ChemMedChem 2013, 8, 385−395.
(8) Lassalas, P.; Gay, B.; Lasfargeas, C.; James, M. J.; Tran, V.;
Vijayendran, K. G.; Brunden, K. R.; Kozlowski, M. C.; Thomas, C. J.;
Smith, A. B., 3rd; Huryn, D. M.; Ballatore, C. Structure Property
Relationships of Carboxylic Acid Isosteres. J. Med. Chem. 2016, 59,
3183−3203.
̈
(25) Hartmann, F.; Klaui, W.; Kremer-Aach, A.; Mootz, D.; Strerath,
A.; Wunderlich, H. Wie Steuert man die Koordination in
Zinkkomplexen?? Untersuchungen mit Hydridotris(3-
phenylpyrazolyl)borat als Ligand. Z. Anorg. Allg. Chem. 1993, 619,
2071−2076.
(26) Rombach, M.; Gelinsky, M.; Vahrenkamp, H. Coordination
Modes of Aminoacids to Zinc. Inorg. Chim. Acta 2002, 334, 25−33.
(27) DuBois, R. M.; Slavish, P. J.; Baughman, B. M.; Yun, M. K.;
Bao, J.; Webby, R. J.; Webb, T. R.; White, S. W. Structural and
Biochemical Basis for Development of Influenza Virus Inhibitors
Targeting the PA Endonuclease. PLoS Pathog. 2012, 8, e1002830.
(28) Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic Anhydrase
Inhibitors. Med. Res. Rev. 2003, 23, 146−189.
(9) Erlanson, D. A.; Fesik, S. W.; Hubbard, R. E.; Jahnke, W.; Jhoti,
H. Twenty Years On: The Impact of Fragments on Drug Discovery.
Nat. Rev. Drug Discovery 2016, 15, 605−619.
(10) Cohen, S. M. A Bioinorganic Approach to Fragment-Based
Drug Discovery Targeting Metalloenzymes. Acc. Chem. Res. 2017, 50,
2007−2016.
(11) Jacobsen, J. A.; Fullagar, J. L.; Miller, M. T.; Cohen, S. M.
Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-
Based Approach. J. Med. Chem. 2011, 54, 591−602.
(12) Chen, A. Y.; Thomas, P. W.; Stewart, A. C.; Bergstrom, A.;
Cheng, Z.; Miller, C.; Bethel, C. R.; Marshall, S. H.; Credille, C. V.;
Riley, C. L.; Page, R. C.; Bonomo, R. A.; Crowder, M. W.; Tierney, D.
L.; Fast, W.; Cohen, S. M. Dipicolinic Acid Derivatives as Inhibitors of
New Delhi Metallo-beta-lactamase-1. J. Med. Chem. 2017, 60, 7267−
7283.
(29) Di Fiore, A.; Maresca, A.; Supuran, C. T.; De Simone, G.
Hydroxamate Represents a Versatile Zinc Binding Group for the
Development of New Carbonic Anhydrase Inhibitors. Chem.
Commun. 2012, 48, 8838−8840.
(13) Credille, C. V.; Chen, Y.; Cohen, S. M. Fragment-Based
Identification of Influenza Endonuclease Inhibitors. J. Med. Chem.
2016, 59, 6444−6454.
(14) Perez, C.; Li, J.; Parlati, F.; Rouffet, M.; Ma, Y.; Mackinnon, A.
L.; Chou, T. F.; Deshaies, R. J.; Cohen, S. M. Discovery of an
Inhibitor of the Proteasome Subunit Rpn11. J. Med. Chem. 2017, 60,
1343−1361.
(15) Puerta, D. T.; Cohen, S. M. Elucidating Drug-Metalloprotein
Interactions with Tris(pyrazolyl)borate Model Complexes. Inorg.
Chem. 2002, 41, 5075−5082.
(16) Tam, K. Y.; Takacs-Novak, K. Multi-Wavelength Spectropho-
tometric Determination of Acid Dissociation Constants: A Validation
Study. Anal. Chim. Acta 2001, 434, 157−167.
(17) Schonherr, D.; Wollatz, U.; Haznar-Garbacz, D.; Hanke, U.;
Box, K. J.; Taylor, R.; Ruiz, R.; Beato, S.; Becker, D.; Weitschies, W.
Characterisation of Selected Active Agents Regarding pK(a) Values,
Solubility Concentrations and pH Profiles by SiriusT3. Eur. J. Pharm.
Biopharm. 2015, 92, 155−170.
(18) Slater, B.; Mccormack, A.; Avdeef, A.; Comer, J. E. A. Ph-
Metric Log-P 0.4. Comparison of Partition-Coefficients Determined
by Hplc and Potentiometric Methods to Literature Values. J. Pharm.
Sci. 1994, 83, 1280−1283.
(19) Monnard, F. W.; Heinisch, T.; Nogueira, E. S.; Schirmer, T.;
Ward, T. R. Human Carbonic Anhydrase II as a Host for Piano-Stool
Complexes Bearing a Sulfonamide Anchor. Chem. Commun. 2011, 47,
8238−8240.
(20) Dowell, R. I.; Hales, N. H.; Tucker, H. Novel Inhibitors of
Prolyl 4-Hydroxylase. Part 4 Pyridine-2-Carboxylic Acid Analogues
with Alternative 2-Substituents. Eur. J. Med. Chem. 1993, 28, 513−
516.
F
Inorg. Chem. XXXX, XXX, XXX−XXX